openPR Logo
Press release

Platelet and Plasma Market : Illustrious Companies - America’s Blood Centers, American Red Cross, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, Sau

10-08-2018 08:10 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Platelet and Plasma Market : Illustrious Companies -

Platelets And Plasma Market will exceed USD 6.5 billion by 2024; as per a new research report.

Increasing number of blood transfusion in regions such as Europe will drive the growth of platelets and plasma market over the forecast period. Millions of people receive donated blood and its components each year. As per the statistics of the European commission over 20 million units of blood or blood components were transfused in 2017. Many developed countries provide a mixed system of compensated as well non-compensated blood donation. Moreover, various government initiatives to encourage blood donation among people will further accelerate the market growth during the forthcoming years.

Growing incidences of rare and infectious diseases such as hepatitis, hemophilia, thrombotic thrombocytopenic purpura will serve to be another impact rendering factor in the growth of platelets and plasma market. Around 3.2 million people in the U.S. are affected by Hepatitis C ultimately leading to hepatocellular carcinoma. Use of platelets and plasma in treatment of hepatocellular carcinoma and other liver diseases will fuel the demand for platelets and plasma. However, lack of treatment affordability in developing countries such as India, China, Brazil and Mexico as well as stringent regulations imposed on plasma collection will restrain the industry growth to some extent throughout the analysis period.

Request sample copy of this report @

Platelet segment is expected to generate highest revenue of around USD 4.5 billion in 2024, owing to the rising number of surgeries being performed coupled with increasing demand for minimally invasive procedures worldwide. Demand for platelets and its analogs is increasing in recent years owing to its varied prophylactic and therapeutic benefits. Growing incidences of chronic and rare diseases worldwide will further augment the market growth during the forecast period. Furthermore, rising disposable income leading to increasing affordability, developments in healthcare infrastructure as well as growing adoption of advanced technologies will accelerate the growth of platelets and plasma market in the coming years.

Thrombocytopenia segment will grow at a robust CAGR of around 2.9% over the foreseeable period attributable to the growing number of thrombocytopenia cases worldwide. Thrombocytopenia is characterized by reduced platelet count owing to number of factors such as chemotherapy drugs, heavy alcohol consumption and leukemia. According to the Journal of Hepatology, thrombocytopenia is commonly found in around 76% patients suffering from chronic liver diseases. Rising prevalence of rare infectious diseases coupled with growing elderly population base will fuel the demand for platelets and plasma over the forecast period.

Hospitals segment dominated the market in 2017 with a revenue share of around 62.5% and is estimated to show remarkable growth in the coming years. Rising number of hospitalizations owing to prevalence of chronic diseases such as hepatitis C, hemophilia and other rare diseases will drive the platelets and plasma market growth during the analysis period. Availability of advanced healthcare facilities, growing elderly patient base as well as reimbursement policies for hospital treatments will upsurge the size of platelets and plasma market during the analysis timeframe.

U.S. platelets and plasma market accounted for the highest revenue of USD 2 billion in 2017 owing to the rising incidences of chronic diseases coupled with increasing geriatric population base will augment the market growth. For instance, plasma is used in the treatment of neurological disorders such as multiple sclerosis, inflammatory dysimmune neuropathies and myasthenia gravis. High adoption of technological advancements as well as availability of advanced healthcare facilities will drive the market growth. Moreover, increased smoking, lifestyle changes and other environmental factors will further boost the demand for platelets and plasma during the forthcoming years.

Make Inquiry about this report @

Some of the notable industry players of global platelets and plasma market are America's Blood Centers, American Red Cross, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, Saudi Red Crescent Authority and South Africa Red Cross Society. Industry players are primarily focusing on developing novel technologies to diversify the product applications for treatment of various diseases. They are also emphasizing on mergers, partnerships and collaborations to encourage blood donation and use of blood components in disease treatments.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Platelet and Plasma Market : Illustrious Companies - America’s Blood Centers, American Red Cross, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, Sau here

News-ID: 1285683 • Views: 230

More Releases from Global Market Insights, Inc.

Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products. Prenatal vitamin ingredients can

All 5 Releases

More Releases for Red

Inaugural Spring 2020 Season Red Oak, March 9, 2020 - On today's date, the Red Oak Soccer Association along with the City of Red Oak, after 12 years of Red Oak teams playing home soccer games in Glenn Heights and Waxahachie, have come to an agreement allowing the Red Oak Soccer Association to play home games within the city of Red Oak. Beginning this Spring Season, with a start date of March
Platelet and Plasma markets Share Trends Analysis Growth: America's Blood Center …
Rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According to American Academy of Neurology, plasma can be used for treatment of various neurological conditions. Plasma exchange process involves replacing plasma in a person’s blood. This process can be used for treatment of conditions such as inflammatory dysimmune neuropathies, multiple
Red Hat Expands Red Hat Developer Program with No-Cost Red Hat Enterprise Linux …
DUBAI, UAE, 3rd April, 2016 – Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, today announced the availability of a no-cost Red Hat Enterprise Linux subscription, available as part of the Red Hat Developer Program. Offered as a self-supported, non-production developer subscription, the Red Hat Enterprise Linux Developer Suite provides developers with a more stable development platform for building enterprise-grade applications and enables a clear
Red Hat Updates Red Hat Academy, Brings Red Hat OpenStack Cloud Technology Educa …
DUBAI, United Arab Emirates, 14th January, 2014 - Red Hat, Inc. (NYSE: RHT), the world’s leading provider of open source solutions, today announced updates to Red Hat Academy, the company’s open source education program that offers turnkey curriculum materials for educational programs in global secondary and higher education institutions. Red Hat has expanded Red Hat Academy to include content on Red Hat Enterprise Linux OpenStack Platform and Red Hat JBoss
Red Hat Launches Latest Version of Red Hat Enterprise Linux 6
DUBAI, United Arab Emirates - 26th November, 2013 - Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, today announced the general availability of Red Hat Enterprise Linux 6.5, the latest version of Red Hat Enterprise Linux 6. Red Hat Enterprise Linux 6.5 expands Red Hat’s vision of providing an enterprise platform that has the stability to free IT to take on major infrastructure challenges and
Red Hat Releases Red Hat Enterprise Linux 6.2
DUBAI, United Arab Emirates, 11th December, 2011 – Red Hat, Inc. (NYSE: RHT), the world’s leading provider of open source solutions, today announced the general availability of Red Hat Enterprise Linux 6.2. With this milestone, Red Hat includes many enhancements that deliver benefits spanning multiple areas, including performance and scalability. Red Hat Enterprise Linux 6 operating system achieved the largest multi-core Linux configuration results certified to-date on the two-tier SAP®